Author:
Yu Lijun,Wu Jianrong,Liu Jia,Zhan Xiaobei,Zheng Zhiyong,Lin Chi Chung
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference29 articles.
1. Harada, T., K. Fujimori, S. Hirose, and M. Masada (1966) Growth and glucan (10C3K) production by a mutant of Alcaligenes faecalis vax. myxogenes in defined medium. Agric. Biol. Chem. 30: 764–769.
2. Jagodzinski, P. P., R. Wiaderkiewicz, G. Kurzawski, M. Kloczewiak, and H. Nakashima (1994) Mechanism of the inhibitory effect of curdlan sulfate on HIV-I infection in vitro. Virology 202: 735–745.
3. Mikio, K., O. Yoshiro, O. Hirotomo, K. Yoshikazu, I. Hiroshi, M. Hisashi, and K. Takeshi (1995) Water soluble β-(1,3)-glucan derivative and antiviral agent containing the derivative. Jpn Patent 07228601.
4. Evans, S. G., D. Morrison, Y. Kaneko, and I. Havlik (1998) The effect of curdlan sulfate on development in vitro of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 92: 87–89.
5. Sutherland, I. W. and D. C. Elwood (1979) Microbial exopolysaccharide-industrial polymers of current and future potentia1. pp. 422–427. In: Bull A. T. (ed.). Microbial Technology: Current States and Future Prospects. Cambridge University Press, London.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献